Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000950170-23-047497

Director acquired 5,437 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Phillips Gary M. Director 2023-09-07 Option exercise +5,437 $0.55 $3,001 14,812 D
Derivatives
Phillips Gary M. Director 2023-09-07 Option exercise · Stock Option (Right to Buy) −5,437 0 D
Loading xslF345X05/ownership.xml…